Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosis

European Respiratory Journal

Volumn 40, Issue 4, 2012, Pages 905-912

  Tazi, Abdellatif ^a   Marc, Karima ^a   Dominique, Stéphane ^b   De Bazelaire, Cédric ^a   Crestani, Bruno ^a   Chinet, Thierry ^c   Israel Biet, Dominique ^a   Cadranel, Jacques ^d   Frija, Jacques ^a   Lorillon, Gwenael ^a   Valeyre, Dominique ^e   Chevret, Sylvie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITÉ PARIS 13   (France)

Author keywords

Airway obstruction; Diffuse cystic lung disease; Multicentre study; Smoking cessation

Indexed keywords

PREDNISONE; STEROID; VINBLASTINE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DIFFUSING CAPACITY FOR CARBON MONOXIDE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL ASSESSMENT; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LANGERHANS CELL HISTIOCYTOSIS; LUNG CYST; LUNG DISEASE; LUNG FUNCTION TEST; LUNG NODULE; MALE; OUTCOME ASSESSMENT; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY LANGERHANS CELL HISTIOCYTOSIS; RESPIRATORY TRACT PARAMETERS; RETROSPECTIVE STUDY; SMOKING CESSATION; SMOKING HABIT;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LONGITUDINAL STUDIES; MALE; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SMOKING CESSATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84867129780     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00210711     Document Type: Article

References (26)

1. Abbott GF, Rosado-de-Christenson ML, Franks TJ, et al. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Radiographics 2004; 24: 821-841. (Pubitemid 38703247)
2. Sundar KM, Gosselin MV, Chung HL, et al. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 2003; 123: 1673-1683. (Pubitemid 36549791)
3. Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 2006; 27: 1272-1285. (Pubitemid 44914314)
4. Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000; 342: 1969-1978. (Pubitemid 30419093)
5. Basset F, Corrin B, Spencer H, et al. Pulmonary histiocytosis X. Am Rev Respir Dis 1978; 118: 811-820. (Pubitemid 9066033)
6. Delobbe A, Durieu J, Duhamel A, et al. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 1996; 9: 2002-2006.
7. Schonfeld N, Frank W, Wenig S, et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993; 60: 38-44. (Pubitemid 23117206)
8. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17: 971-986. (Pubitemid 23289339)
9. Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002; 346: 484-490. (Pubitemid 34441739)
10. Brauner MW, Grenier P, Tijani K, et al. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997; 204: 497-502. (Pubitemid 27337502)
11. Canuet M, Kessler R, Jeung MY, et al. Correlation between high-resolution computed tomography findings and lung function in pulmonary Langerhans cell histiocytosis. Respiration 2007; 74: 640-646. (Pubitemid 350164509)
12. Moore AD, Godwin JD, Muller NL, et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989; 172: 249-254. (Pubitemid 19192518)
13. Abbritti M, Mazzei MA, Bargagli E, et al. Utility of spiral CAT scan in the follow-up of patients with pulmonary Langerhans cell histiocytosis. Eur J Radiol 2011; [Epub ahead of print DOI: 10.1016/j.ejrad.2011.04.018].
14. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 1-100.
15. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. (Pubitemid 32378468)
16. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63: Suppl. 5, v1-v58.
17. Kohansal R, Martinez-Camblor P, Agusti A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180: 3-10.
18. Kambouchner M, Basset F, Marchal J, et al. Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis. Am J Respir Crit Care Med 2002; 166: 1483-1490. (Pubitemid 35387299)
19. McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest 2008; 133: 507-516. (Pubitemid 351272412)
20. Chaowalit N, Pellikka PA, Decker PA, et al. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc 2004; 79: 1269-1275. (Pubitemid 39299072)
21. Dauriat G, Mal H, Thabut G, et al. Lung transplantation for pulmonary Langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006; 81: 746-750.
22. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216-223. (Pubitemid 30055928)
23. Hamada K, Teramoto S, Narita N, et al. Pulmonary veno-occlusive disease in pulmonary Langerhans' cell granulomatosis. Eur Respir J 2000; 15: 421-423. (Pubitemid 30085976)
24. Le Pavec J, Lorillon G, Jais X, et al. Pulmonary arterial hypertension associated with pulmonary Langerhans cell histiocytosis: impact of pulmonary hypertension therapy. Am J Respir Crit Care Med 2011; 183: A5916.
25. Sadoun D, Vaylet F, Valeyre D, et al. Bronchogenic carcinoma in patients with pulmonary histiocytosis X. Chest 1992; 101: 1610-1613.
26. Vassallo R, Ryu JH. Tobacco smoke-related diffuse lung diseases. Semin Respir Crit Care Med 2008; 29: 643-650.